94 results
F-10
EX-4.4
BLU
Bellus Health Inc
23 Feb 05
Registration of securities (Canada)
12:00am
commitment by Francesco
Bellini, Chairman and CEO, to remain with the Company in an executive capacity
for at least three more years. Dr. Bellini also … assumes the office of President.
This commitment was evidenced by the three year renewal of the management
services agreement between Neurochem
6-K
EX-99.2
BLU
Bellus Health Inc
1 Apr 09
Bellus Health Inc. Provides Financing Update and Announces Restructuring of Existing Notes
12:00am
. $10.5 million of such notes, for a total financing commitment of Cdn. $20.5 million.
The Company also announced that three senior executives … and Victoria Square Ventures Inc. has committed to purchase Cdn. $10.5 million of such notes, for a total financing commitment of Cdn. $20.5 million
6-K/A
BLU
Bellus Health Inc
21 Feb 08
Current report (foreign) (amended)
12:00am
study should be submitted as part of a Phase IV (post-approval) commitment.
Neurochem has also submitted for marketing approval eprodisate (KIACTA™ … of Amendment No. 2:
The definition of “Commitment Period” set forth in Section 1.1 of Article I (Definitions) of the Agreement is deleted
6-K
BLU
Bellus Health Inc
21 Feb 08
Current report (foreign)
12:00am
be submitted as part of a Phase IV (post-approval) commitment.
Neurochem has also submitted for marketing approval eprodisate (KIACTA™) for the treatment … :
The definition of “Commitment Period” set forth in Section 1.1 of Article I (Definitions) of the Agreement is deleted and replaced in its entirety
6-K
EX-99.1
BLU
Bellus Health Inc
1 Apr 09
Bellus Health Inc. Provides Financing Update and Announces Restructuring of Existing Notes
12:00am
financing commitment of Cdn. $20.5 million. The obligations of each of the Investors to subscribe for such notes are subject to a number of customary … . They have demonstrated constant commitment and dedication to the Company, and they have each made major contributions. We are grateful to them
6-K
xvddz
20 Apr 05
Current report (foreign)
12:00am
6-K
0bwyhxep
18 Jul 07
Current report (foreign)
12:00am
6-K
9np h7t1wqglwog0t6
21 Jan 04
Current report (foreign)
12:00am
6-K
EX-99.1
jqe9odl 23
21 Oct 08
Current report (foreign)
12:00am
6-K
3z05fl5x1jv0b
9 Dec 03
Current report (foreign)
12:00am
6-K
tcqjsq8nzaa2ee6o
14 Aug 06
Current report (foreign)
12:00am
6-K
diugap 63lga
18 Jul 07
Current report (foreign)
12:00am
6-K
djvd1nqh0dbdcqwf75f
20 Jan 05
Current report (foreign)
12:00am
6-K
eu9e 8js9b3k2nvc
19 Apr 05
Current report (foreign)
12:00am
6-K
EX-99.3
8zjdg6lvye123syh7
27 Apr 23
Material Change Report
6:04am
6-K
EX-99.1
y1htz2r9c985bf 355e
18 Apr 23
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health
6:02am
6-K
lp3wgyuorbfvg2p1iwv
8 Nov 07
Current report (foreign)
12:00am
6-K
EX-99.1
cjhexhwo
9 Apr 09
Bellus Health Inc. Provides an Update on the Financing and the Restructuring of Existing Notes
12:00am
6-K
bucvh 88si
21 Apr 04
Current report (foreign)
12:00am
SUPPL
xng32wog d4ugwua10r
4 Mar 05
Supplemental materials (foreign)
12:00am